Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Deloitte
Express Scripts
Colorcon
Medtronic

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 5,756,552

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,756,552
Title: Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
Abstract:Herein disclosed is a lyophilized pharmaceutical preparation obtained by lyophilizing an aqueous composition having property of reversible thermosetting gelation and comprising an effective amount of a drug, 0.2 to 2.1 (W/V)% of methylcellulose (the content of methoxyl group is within the range of 26 to 33%), 1.2 to 2.3 (w/v)% of citric acid and 0.5 to 13 (W/V)% of polyethylene glycol. The lyophilized pharmaceutical preparation makes it possible to stably store drugs unstable to water till they are put into practical use and, upon therapeutic use, an aqueous composition having property of reversible thermosetting gelation which can undergo gelation when locally applied can easily and immediately be reconstituted from the preparation by addition of a proper amount of a solvent for reconstitution.
Inventor(s): Takeuchi; Masanobu (Nihonbashi-Muromachi, JP), Suzuki; Hiroe (Nihonbashi-Muromachi, JP), Takahashi; Toshie (Nihonbashi-Muromachi, JP), Maruyama; Hiroki (Nihonbashi-Muromachi, JP), Sasaki; Miyako (Nihonbashi-Muromachi, JP), Naito; Keiko (Nihonbashi-Muromachi, JP), Oguma; Touru (Nihonbashi-Muromachi, JP), Maeda; Makoto (Nihonbashi-Muromachi, JP)
Assignee: Wakamoto Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:08/809,604
Patent Claims:see list of patent claims

Details for Patent 5,756,552

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Wakamoto Pharmaceutical Co., Ltd. (Tokyo, JP) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Cipla
McKinsey
Citi
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.